STERIS plc (STE)

NYSE: STE · IEX Real-Time Price · USD
224.82
-0.70 (-0.31%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

STERIS plc provides infection prevention products and services worldwide.

It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.

The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.

The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities.

The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors.

This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.

The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite.

The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers.

The company was founded in 1985 and is based in Dublin, Ireland.

STERIS plc
STERIS logo
Country Ireland
Founded 1985
IPO Date Jun 1, 1992
Industry Medical Devices
Sector Healthcare
Employees 17,100
CEO Daniel A. Carestio

Contact Details

Address:
70 Sir John Rogerson's Quay
Dublin, L2 2
Ireland
Phone 35312322000
Website steris.com

Stock Details

Ticker Symbol STE
Exchange NYSE
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001757898
CUSIP Number G8473T100
ISIN Number IE00BFY8C754
SIC Code 3842

Key Executives

Name Position
Daniel A. Carestio President, Chief Executive Officer and Director
Michael J. Tokich Senior Vice President and Chief Financial Officer
John Adam Zangerle Senior Vice President, General Counsel and Secretary
Mary Clare Fraser SVice President and Chief Human Resources Officer
Cary L. Majors Senior Vice President and President of Healthcare
Karen L. Burton Chief Accounting Officer, Vice President and Controller
Julie Winter Vice President of Investor Relations and Corporate Communications
Julia K. Madsen Senior Vice President of Life Sciences
Andrew Xilas Senior Vice President and GM of Dental
Kenneth E. Kohler Senior Vice President and GM of AST

Latest SEC Filings

Date Type Title
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 8, 2024 10-Q Quarterly Report
Feb 7, 2024 8-K Current Report
Jan 30, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Dec 6, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 7, 2023 10-Q Quarterly Report
Nov 7, 2023 8-K Current Report
Nov 7, 2023 8-K/A [Amend] Current report